Laboratory Tests for Hematuria and Flank Pain
For a patient presenting with hematuria and flank pain, order: urinalysis with microscopy, urine culture (if infection suspected), and serum creatinine. 1
Essential Laboratory Workup
Core Tests
Urinalysis with microscopy is the cornerstone of evaluation 1. This must include:
- Quantification of RBCs per high-power field - Document the exact number, as this drives subsequent management
- Assessment for dysmorphic RBCs or red cell casts - These indicate glomerular disease requiring nephrology referral 1
- Proteinuria testing - Significant proteinuria suggests renal parenchymal disease 1
- Evaluation for pyuria and bacteriuria - To identify urinary tract infection 2, 1
Serum creatinine should be measured in all patients to assess renal function 1. This is critical because renal insufficiency combined with hematuria suggests glomerular disease.
When to Add Urine Culture
Order urine culture if urinalysis shows evidence of infection (pyuria, bacteriuria) 1. Obtain this preferably before starting antibiotics 2. If infection is confirmed, repeat urinalysis 6 weeks after treatment - if hematuria resolves, no further evaluation is needed 1.
Risk Stratification Based on Labs
Indicators of Glomerular Disease (Nephrology Referral)
The presence of any of these findings mandates nephrology evaluation 1:
- Significant proteinuria
- Red cell casts
- Renal insufficiency (elevated creatinine)
- Predominance of dysmorphic RBCs (>5% acanthocytes suggests glomerular origin) 3
Indicators of Urologic Disease (Imaging + Urology)
If the above glomerular markers are absent, proceed with urologic evaluation 1. The flank pain component strongly suggests urolithiasis or other structural urologic pathology 2.
Additional Testing Based on Risk Factors
Urine Cytology
Order urine cytology only if the patient has risk factors for transitional cell carcinoma 1:
- Age >40 years
- Smoking history
- Occupational chemical exposure
- Gross hematuria
- Irritative voiding symptoms
- History of pelvic irradiation
- Chronic UTI or indwelling catheter
The 2025 AUA/SUFU guideline specifically recommends against routine use of urine cytology or tumor markers for deciding whether to perform cystoscopy 4. Cytology has limited sensitivity (57.7%) and should not replace cystoscopy in high-risk patients 4.
Critical Pitfalls to Avoid
Do not rely on dipstick alone - Dipstick has 94% sensitivity but only 6% specificity 5. Always confirm with microscopy showing ≥3 RBCs per high-power field 2.
Do not assume absence of hematuria excludes stones - In patients with flank pain and suspected urolithiasis, 11-19% have no RBCs on urinalysis despite confirmed stones on CT 6, 7. The sensitivity of hematuria for detecting stones is only 77-84% 7, 8.
Do not skip evaluation if hematuria resolves - Gross hematuria has 30-40% association with malignancy 2. Even self-limited gross hematuria requires full urologic workup.
Algorithmic Approach
- Obtain urinalysis with microscopy + serum creatinine in all patients
- If glomerular markers present → Nephrology referral (though this doesn't preclude urologic evaluation) 1
- If infection suspected → Add urine culture, treat, repeat UA in 6 weeks
- If high-risk for malignancy → Add urine cytology (though cystoscopy will still be needed)
- Proceed to imaging (CT urography preferred 2) regardless of hematuria presence/absence given flank pain 6, 7
The combination of hematuria and flank pain most commonly indicates urolithiasis 2, but the differential includes renal cell carcinoma, urothelial cancer, renal trauma, vascular lesions, and glomerulonephritis 2, 1. Laboratory testing guides the pathway but does not replace imaging in symptomatic patients.